Exercise Movement Techniques
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Be controlled hypertensive; regardless of the class of medication used and the combination of two or more medications; be between 30 and 59 years of age; be sedentary for at least six months; have a body mass index of up to 30 kilos per square meter; not using contraceptives or under hormonal replacement; having medical clearance to practice physical exercise; not having osteomioarticular disease that could compromise the partial or total performance of the proposed exercises; not having any other disease that could compromise the cardiovascular; respiratory or metabolic to exercise; do not have diabetes mellitus; do not smoke or drink alcohol; do not have damage to a target organ; such as nephropathy; heart disease; etc. and accept to be a project volunteer. Only women with BP will be included in the study. Controlled; that is; who are undergoing drug treatment of any class. All volunteers included in the study signed an informed consent form.
Exclusion criteria
Exclusion criteria: Women who during the experimental period 4 months; have changes in drug treatment as class; dose; drug interaction and those who; at the end of 16 weeks of physical training; have a frequency below 75% or who have had two or more consecutive absences in training.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in biochemical (metabolic) parameters assessed by laboratory tests performed before and after the intervention period.;Improvement/increase in respiratory capacity (inspiratory and expiratory) of at least 20%, assessed by the Pulmonary Function Test (Spirometry) before and after the intervention period.;Improvement in cardiorespiratory capacity and physical conditioning, assessed by the cardiorespiratory exercise test - maximal effort test, before and after the intervention period.;Diastolic blood pressure reduction, on average 3mmHg, assessed by ECG and ABPM before and after the intervention period.;Systolic blood pressure reduction, on average of 7mmHg, assessed by ECG and ABPM before and after the intervention period. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in anthropometric indices, assessed by stadiometer and measuring tape, before and after the intervention period. | — |
Countries
Brazil